Matsubara, Nobuaki
Kimura, Go
Uemura, Hiroji
Uemura, Hirotsugu
Nakamura, Motonobu
Nagamori, Satoshi
Mizokami, Atsushi
Kikukawa, Hiroaki
Hosono, Makoto
Kinuya, Seigo
Krissel, Heiko
Siegel, Jonathan
Kakehi, Yoshiyuki
Funding for this research was provided by:
Bayer CropScience
Bayer
Astellas Pharma
Janssen Pharmaceuticals
Takeda Pharmaceutical Company
AstraZeneca
Sanofi
Article History
Received: 9 September 2019
Accepted: 24 November 2019
First Online: 10 December 2019
Compliance with ethical standards
:
: The authors disclose the following conflicts of interest: Nobuaki Matsubara has received research funding from Bayer. Go Kimura has received honoraria from Bayer. Hiroji Uemura has received research funding from Astellas, honoraria from Bayer, Janssen, Astellas, Takeda and Astra Zeneca, and received travel expenses from Janssen, Bayer, Astellas, Takeda and Astra Zeneca. Hirotsugu Uemura has received research funding from Astra Zeneca, Sanofi, Janssen, Takeda and Astellas, honoraria from Bayer, Astra Zeneca, Takeda, Sanofi, Janssen and Astellas, and has acted as an advisor to Sanofi, Janssen, and Bayer. Atsushi Mizokami has received honoraria from Bayer. Seigo Kinuya has received honoraria from Bayer. Heiko Krissel and Jonathan Siegel own stocks of Bayer AG, and are employees of Bayer AG and Bayer HealthCare Pharmaceuticals, respectively. All remaining authors declare no conflict of interest.